X
20
Fresenius Kabi Oncology Limited Kalyani In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Busulfan, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2010-374 - Rev 07
This Chemical Type CEP, issued on October 13, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 542 associated with this CEP further emphasizes